荃信生物-B(02509)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02509 荃信生物-B

休市中 06-18 16:08:08

14.280

-0.010

-0.07%

最高14.600	最低13.970	成交量13.54万
今开14.410	昨收14.290	日振幅4.41%
总市值31.84亿	流通市值31.84亿	总股本2.23亿
成交额192.78万	换手率0.06%	流通股本2.23亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02509","market":"HK","secType":"STK","nameCN":"荃信生物-B","latestPrice":14.28,"timestamp":1781770088007,"preClose":14.29,"halted":0,"volume":135400,"delay":0,"changeRate":-0.0006997900629810908,"floatShares":223000000,"shares":223000000,"eps":1.41,"marketStatus":"休市中","change":-0.01,"latestTime":"06-18 16:08:08","open":14.41,"high":14.6,"low":13.97,"amount":1927822,"amplitude":0.044087,"askPrice":14.28,"askSize":200,"bidPrice":13.91,"bidSize":200,"shortable":3,"etf":0,"ttmEps":1.564286,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782091800000},"marketStatusCode":7,"adr":0,"listingDate":1710864000000,"exchange":"SEHK","adjPreClose":14.29,"openAndCloseTimeList":[[1781746200000,1781755200000],[1781758800000,1781769600000]],"volumeRatio":0.8022895463664915,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02509/tweets","defaultTab":"tweets","newsList":[{"id":"1143912773","title":"荃信生物-B：6月18日回购1.1万股股份，涉资约15.71万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1143912773","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143912773?lang=zh_cn&edition=full","pubTime":"2026-06-18 17:47","pubTimestamp":1781776059,"startTime":"0","endTime":"0","summary":"荃信生物-B于2026年6月18日发布公告称，公司于当日在香港联交所场内回购11,000股H股股份，占该日前已发行股份总数约0.0049%。本次回购价格为每股14.28港元，合计支出157,080港元。荃信生物-B的股东大会已于2026年5月29日通过购回授权，授权购回股份总数量为22,436,340股，截至目前公司已根据相关授权在包括香港联交所在内的证券交易所累计购回961,000股。公司确认已根据香港联交所上市规则的规定履行相关程序和义务。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"荃信生物-B：6月18日回购1.1万股股份，涉资约15.71万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148130223","title":"荃信生物-B6月17日回购25,800股，涉资约36.95万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1148130223","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148130223?lang=zh_cn&edition=full","pubTime":"2026-06-17 18:22","pubTimestamp":1781691720,"startTime":"0","endTime":"0","summary":"荃信生物-B于2026年6月17日发布公告称，公司当日于香港联交所场内回购25,800股H股，占当日回购前公司已发行股本约0.0115%。回购价介乎每股14.20港元至14.49港元，合计涉资约369,538.56港元。本次回购完成后，公司已发行股份总数为227,071,600股，其中不含库存股份的发行股数为223,413,400股，库存股份增至3,658,200股。公司于2026年5月29日获得股东大会通过购回授权，允许最多购回22,436,340股。公司确认，本次回购行为符合香港联交所主板上市规则及相关法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"荃信生物-B6月17日回购25,800股，涉资约36.95万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644103797","title":"荃信生物-B(02509)6月17日斥资36.95万港元回购2.58万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2644103797","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644103797?lang=zh_cn&edition=full","pubTime":"2026-06-17 18:16","pubTimestamp":1781691375,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)发布公告，于2026年6月17日，该公司斥资36.95万港元回购2.58万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1455628.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119771772","title":"荃信生物-B回购3.4万股股份，耗资约49.77万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1119771772","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119771772?lang=zh_cn&edition=full","pubTime":"2026-06-16 19:51","pubTimestamp":1781610681,"startTime":"0","endTime":"0","summary":"2026年6月16日，江蘇荃信生物醫藥股份有限公司发布公告，披露了最新的股份购回情况，显示公司于当日回购H股股份3.4万股。回购价格介乎每股港币14.32元至15元，合计耗资港币497,726元，折合约49.77万港元。本次回购后，公司不含库存股的股份总数为223,439,200股，库存股数为3,632,400股，已发行股本总数保持在227,071,600股。截至目前，累计回购股份数量为924,200股。公告由董事会秘书和联席公司秘书胡衍保签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"荃信生物-B回购3.4万股股份，耗资约49.77万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104810391","title":"荃信生物-B6月15日回购4.12万股，耗资约62.98万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1104810391","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104810391?lang=zh_cn&edition=full","pubTime":"2026-06-15 22:01","pubTimestamp":1781532112,"startTime":"0","endTime":"0","summary":"江蘇荃信生物醫藥股份有限公司于2026年6月15日发布公告，披露当日于香港联交所回购股份事宜。根据公告，本次公司购回股份41,200股，相当于该次回购前已发行股本约0.0184%。回购价格区间介于每股15.00港元至15.50港元，合计支付约62.98万港元。\\n\\n本次回购完成后，公司已发行股本变动为223,473,200股，库藏股增至3,598,400股，总股本仍为227,071,600股。\\n\\n公司在公告中指出，已遵守香港联合交易所有限公司证券上市规则及相关法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"荃信生物-B6月15日回购4.12万股，耗资约62.98万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643773209","title":"荃信生物-B(02509)6月15日斥资62.98万港元回购4.12万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2643773209","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643773209?lang=zh_cn&edition=full","pubTime":"2026-06-15 21:59","pubTimestamp":1781531973,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)发布公告，于2026年6月15日斥资62.98万港元回购4.12万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1454655.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159737132","title":"荃信生物-B回购1万股，涉资约15.96万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1159737132","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159737132?lang=zh_cn&edition=full","pubTime":"2026-06-12 21:11","pubTimestamp":1781269863,"startTime":"0","endTime":"0","summary":"江蘇荃信生物醫藥股份有限公司2026年6月12日公告称，公司于香港联合交易所回购H股普通股1万股，占本次回购前已发行股份总数约0.0045%。回购价格区间每股15.90港元至16.01港元，合计付出约15.96万港元。本次回购后，公司已发行股份总数为227,071,600股，其中库藏股数量为3,557,200股。公司确认，本次回购已遵守香港联合交易所有限公司证券上市规则及相关法例的规定。公告由董事会秘书和联席公司秘书胡衍保签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"荃信生物-B回购1万股，涉资约15.96万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198185081","title":"荃信生物-B：6月11日回购5.14万股，涉资约80.12万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1198185081","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198185081?lang=zh_cn&edition=full","pubTime":"2026-06-11 22:01","pubTimestamp":1781186514,"startTime":"0","endTime":"0","summary":"江蘇荃信生物醫藥股份有限公司于2026年6月11日发布公告，披露公司于当日进行股份回购。本次公司于香港联合交易所场内回购普通股H股51,400股，占当日现有已发行股份总数约0.023%。回购最高价每股15.8港元、最低价每股14.8港元，合计支付金额801,233.48港元，约合80.12万港元。公司于2026年5月29日获股东大会批准的本次回购授权可回购股份数上限为22,436,340股，目前已累计回购839,000股，占授权通过当日已发行股份总数约0.3739%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"荃信生物-B：6月11日回购5.14万股，涉资约80.12万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642828063","title":"荃信生物-B(02509)6月11日斥资80.12万港元回购5.14万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2642828063","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642828063?lang=zh_cn&edition=full","pubTime":"2026-06-11 22:00","pubTimestamp":1781186452,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)发布公告，于2026年6月11日，该公司斥资80.12万港元回购5.14万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453406.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170780645","title":"荃信生物-B：6月10日回购66,600股股份，总金额约99.15万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1170780645","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170780645?lang=zh_cn&edition=full","pubTime":"2026-06-10 18:22","pubTimestamp":1781086925,"startTime":"0","endTime":"0","summary":"2026年6月10日，荃信生物-B公布翌日披露报表，披露于香港联交所场内回购66,600股H股普通股，约占回购前已发行股份总数的0.0298%。本次回购的价格区间为每股14.47港元至15.38港元，合计支付约99.15万港元。本次股份回购完成后，荃信生物-B已发行股份变动为223,575,800股，相应库藏股数量上升至3,495,800股，总已发行股份仍为227,071,600股。公司称，此次回购系根据2026年5月29日通过的股份回购授权进行，授权可回购股份总数为22,436,340股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"荃信生物-B：6月10日回购66,600股股份，总金额约99.15万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642644773","title":"荃信生物-B(02509)6月10日斥资99.15万港元回购6.66万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2642644773","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642644773?lang=zh_cn&edition=full","pubTime":"2026-06-10 18:18","pubTimestamp":1781086687,"startTime":"0","endTime":"0","summary":"荃信生物-B(02509)发布公告，于2026年6月10日，该公司斥资99.15万港元回购6.66万股股份，每股回购价14.47-15.38港元。","market":"us","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_42.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_42.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452658.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"荃信生物-B(02509)6月10日斥资99.15万港元回购6.66万股","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143924298","title":"荃信生物-B自去年11月6日至今年6月9日回购343万股作库存股","url":"https://stock-news.laohu8.com/highlight/detail?id=1143924298","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143924298?lang=zh_cn&edition=full","pubTime":"2026-06-09 23:56","pubTimestamp":1781020590,"startTime":"0","endTime":"0","summary":"6月9日（路透社）—— 荃信生物-B（02509.HK）宣布，公司于2025年11月6日至2026年6月9日期间，在公开市场回购了共计343万股普通股，并计划将这些股份作为库存股持有。此举通常反映了公司管理层对自身长期价值及发展前景的信心，并可能通过减少流通股数量来提升每股收益，为股东创造价值。该股后续动向值得投资者密切关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642629464","title":"荃信生物-B(02509)根据购回授权购回合共342.92万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2642629464","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642629464?lang=zh_cn&edition=full","pubTime":"2026-06-09 19:37","pubTimestamp":1781005061,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)发布公告，本公司董事会认为本公司目前股价严重低估本公司的价值。凭借对本公司未来发展前景的充分信心及对本公司内在价值的高度认同，为持续增强市场对本公司的信心并提升本公司的投资价值，根据本公司股东于2025年6月20日及 2026年5月29日举行的股东周年大会上批准授予本公司董事的股份购回授权，本公司已于2025年11月6日至本公告日期在香港联合交易所有限公司购回合共342.92万股普通股作为库存股。所购回的股份占本公司于本公告日期的现有已发行股份总数约1.51%。于本公告日期，购回涉及的总金额为约6566万港元(不包括佣金及其他开支)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452147.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130427417","title":"荃信生物-B：6月9日回购6.94万股，耗资约104.92万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1130427417","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130427417?lang=zh_cn&edition=full","pubTime":"2026-06-09 18:13","pubTimestamp":1781000015,"startTime":"0","endTime":"0","summary":"江蘇荃信生物醫藥股份有限公司于2026年6月9日发布公告，宣布当日通过香港联交所场内回购股份。本次合计回购69,400股，占回购前公司已发行股份约0.031%，回购价格介乎每股14.75港元至15.40港元，共耗资1,049,223.9港元。公司已于2026年5月29日获得购回授权，可回购股份总数22,436,340股。公司确认，本次回购活动已遵守香港联交所主板上市规则及相关法规，公告由董事会秘书和联席公司秘书胡衍保签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"荃信生物-B：6月9日回购6.94万股，耗资约104.92万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143905786","title":"荃信生物-B6月8日回购3.5万股股份，总额约52.66万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1143905786","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143905786?lang=zh_cn&edition=full","pubTime":"2026-06-08 18:37","pubTimestamp":1780915062,"startTime":"0","endTime":"0","summary":"江蘇荃信生物醫藥股份有限公司于2026年6月8日发布翌日披露报表，宣布当日在香港联交所回购股份。根据公告，回购股份数量为35,000股，占本次回购前公司已发行股份223,746,800股的约0.0156%，回购价格介乎每股港币14.78元至15.30元，合计支付526,645港元，折合约52.66万港元。公司确认，上述回购事宜严格遵守香港联交所主板上市规则及相关法律法规，并由董事会秘书和联席公司秘书胡衍保签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"荃信生物-B6月8日回购3.5万股股份，总额约52.66万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641748594","title":"荃信生物-B(02509)6月8日斥资52.66万港元回购3.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641748594","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641748594?lang=zh_cn&edition=full","pubTime":"2026-06-08 18:32","pubTimestamp":1780914737,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)发布公告，于2026年6月8日，该公司斥资52.66万港元回购3.5万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451502.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126871504","title":"荃信生物-B回购25.32万股股份，耗资约382.60万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1126871504","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126871504?lang=zh_cn&edition=full","pubTime":"2026-06-05 20:31","pubTimestamp":1780662710,"startTime":"0","endTime":"0","summary":"荃信生物-B于2026年6月5日发布翌日披露报表，公告显示公司于当日通过香港联交所场内回购253,200股H股，占回购前已发行股本约0.113%。回购价格介乎14.64港元至15.80港元，以每股成交量加权平均价15.1107港元计算，共耗资约382.60万港元。根据公告信息，公司于2026年5月29日获得购回授权，可回购的股份总数为22,436,340股，迄今已累计购回616,600股，占授权通过当日已发行股本的0.2748%。公司确认已遵守香港联交所主板上市规则及相关法律法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"荃信生物-B回购25.32万股股份，耗资约382.60万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641110079","title":"荃信生物-B(02509)6月5日斥资382.6万港元回购25.32万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641110079","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641110079?lang=zh_cn&edition=full","pubTime":"2026-06-05 20:27","pubTimestamp":1780662455,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)发布公告，于2026年6月5日斥资382.6万港元回购25.32万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450950.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640157677","title":"荃信生物-B(02509)6月4日斥资39.19万港元回购2.52万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640157677","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640157677?lang=zh_cn&edition=full","pubTime":"2026-06-04 20:23","pubTimestamp":1780575792,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)发布公告，于2026年6月4日斥资39.19万港元回购2.52万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450356.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176256270","title":"荃信生物-B6月4日回购2.52万股，耗资约39.19万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1176256270","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176256270?lang=zh_cn&edition=full","pubTime":"2026-06-04 20:22","pubTimestamp":1780575720,"startTime":"0","endTime":"0","summary":"江蘇荃信生物醫藥股份有限公司于2026年6月4日发布翌日披露报表，宣布在香港联交所场内回购25,200股H股。该批股份占回购前公司已发行股本约0.0112%，回购价格区间为每股15.31港元至15.80港元，合计支付金额391,865.04港元。本次回购完成后，公司已发行股份总数变动为224,000,000股，库藏股数量增至3,071,600股，总股份数保持在227,071,600股。荃信生物-B确认已遵守香港联交所证券上市规则及相关法例。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"荃信生物-B6月4日回购2.52万股，耗资约39.19万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.qyuns.net","stockEarnings":[{"period":"1week","weight":-0.091},{"period":"1month","weight":-0.1075},{"period":"3month","weight":-0.1987},{"period":"6month","weight":-0.24},{"period":"1year","weight":-0.048},{"period":"ytd","weight":-0.2396}],"compareEarnings":[{"period":"1week","weight":-0.0134},{"period":"1month","weight":-0.0726},{"period":"3month","weight":-0.0535},{"period":"6month","weight":-0.0687},{"period":"1year","weight":0.009},{"period":"ytd","weight":-0.0666}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"江苏荃信生物医药股份有限公司是一家主要从事自身免疫及过敏性疾病的生物疗法研发、制造及商业化的中国公司。该公司专注于皮肤、风湿、呼吸道及消化道疾病。该公司的产品主要包括赛乐信、奥托奇拜单抗，以及鲁塞奇塔单抗等。该公司在国内和国外市场开展业务。","exchange":"SEHK","name":"荃信生物-B","nameEN":"QYUNS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"荃信生物-B(02509)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供荃信生物-B(02509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"荃信生物-B,02509,荃信生物-B股票,荃信生物-B股票老虎,荃信生物-B股票老虎国际,荃信生物-B行情,荃信生物-B股票行情,荃信生物-B股价,荃信生物-B股市,荃信生物-B股票价格,荃信生物-B股票交易,荃信生物-B股票购买,荃信生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"荃信生物-B(02509)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供荃信生物-B(02509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}